Skip to content

RSA Study of Furlong Evolution With and Without Collar

Evaluation of the Furlong Evolution Uncemented Hip Prosthesis With Special Emphasize on the Use of Collared Design or Not. A Prospective, Randomized Study Evaluated by RadioStereometric Analysis (RSA) and DXA.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01894854
Enrollment
50
Registered
2013-07-10
Start date
2012-10-31
Completion date
2025-03-31
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Replacement in Osteoarthritis Patients

Keywords

Radiostereometry, Total Hip Arthroplasty, Stem design

Brief summary

The aim of this study is to further investigate the clinical and radiological importance of design changes in cementless hip prosthesis. The investigators have earlier evaluated the classical Furlong HAC total hip prosthesis and a first design change Furlong Active. Now a further development, Furlong Evolution, is to be evaluated. This prosthesis, furthermore, comes with and without a collar, and the investigators are going to randomize between the two. The investigators hypothesize that the new design will be easier to implant and will present equal or less migration than the older designs which would imply a favourable outcome in the long term. The investigators further hypothesize that the collar play no major part for the long term migration and bone remodelling. We will now do a 10 year follow up of the patients including RSA, DXA and PROMS

Interventions

PROCEDUREStem collar

The stem has two versions, one with and one without a collar. The classical Furlong HAC had a collar.

Sponsors

JRI Orthopaedics Ltd
CollaboratorINDUSTRY
Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Primary osteoarthritis of the hip necessitating primary hip replacement * A femur considered suitable for uncemented fixation of the stem * Biological age \<75 years old at the inclusion time of the study.

Exclusion criteria

* Rheumatoid arthritis * Malignant disease * Severe osteoporosis * Earlier fracture or operation in the hip to be operated on * Peroperative fracture * Ongoing corticosteroid (oral) or immunosuppressive medication * Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.

Design outcomes

Primary

MeasureTime frameDescription
Radiostereometric Analysis (RSA)The first postoperative day, 14 days, 3 months, 1, 2, 5 and 10 yearsThis will measure the change in migration (translation and rotation around the x-, y-, and z-axis of the hip) over time. The migration pattern the first 2 years can predict the long term outcome.

Secondary

MeasureTime frameDescription
Dual-energy X-ray absorptiometry (DXA)14 days postoperatively and after 1, 5 and 10 yearsThis will measure the change in bone density around the prosthesis during the first important year. This will tell if there is a bone resorption around the stem or cup.
General health questionnairePreoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperativelyEuroQol (EQ-5D) - a standardized instrument for use as measure of general health outcome over time
Hip specific health questionnairePreoperatively (3-4 weeks) and 1, 2, 5 and 10 years postoperativelyHip disability and Osteoarthritis Outcome Score (HOOS) - this is a hip specific questionnaire that will measure how the operation has affected the patients function and pain situation.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026